Oklahoma voters will decide on Tuesday, June 26, on State Question 788 — a statewide voter-initiated measure that permits doctors to use their discretion to recommend medical cannabis to patients. If passed, Oklahoma will become the 31st state to legalize the possession and use of cannabis by authorized patients.
More than two-thirds of chronic pain patients registered to legally access medical cannabis products substitute marijuana for prescription opioids, according to data published in The Journal of Headache and Pain Among those patients diagnosed specifically with headache/migraine, cannabis was frequently reported as a substitute for other medications – including opiates (43 percent), anti-depressants (39 percent), NSAIDS (21 percent), triptans (8 percent), and anti-convulsants (8 percent).
State regulators today certified a voter-initiated medical cannabis access measure for the 2018 ballot. Officials announced that proponents gathered nearly 154,000 validated initiative signatures from registered voters — far exceeding the total necessary to place the measure before a statewide vote.
A Florida Circuit Court judge ruled today that a legislatively enacted ban on the smoking of medical cannabis in private by qualified patients is unconstitutional. “Section 381.986, Florida Statutes (2017) unconstitutionally restricts rights that are protected in the Constitution, and so the statutory prohibition against the use of smokeable marijuana permitted by [a] qualifying patient is declared invalid and unenforceable,” the judge ruled.
By a margin of nearly 2 to 1, Oklahoma voters support the passage of State Question 788 — a voter-initiated measure to permit patients access to marijuana for therapeutic purposes. Oklahomans will decide on the measure in a special election on Tuesday, June 26.
In a ruling issued today by the Arizona Supreme Court, justices upheld an appellate court decision striking down a 2012 law that sought to forbid medical cannabis access on college campuses. Lifetime NORML Legal Committee member Tom Dean represented the patient-defendant in the case pro bono, and called the decision a “victory for democracy.”
Today, the House appropriations committee for the first time heard and passed language, known as the Joyce amendment, to restrict funding for the Department of Justice to prosecute state-legal medical marijuana programs.
In testimony before Congress last week, by DEA acting administrator Robert Patterson opined that the medicalization of cannabis is exacerbating opioid abuse. But when prompted to provide evidence in support of the agency’s position, he acknowledged that he could not.
Board members and activists with New Approach Missouri, a campaign to legalize medical marijuana, submitted more 370,000 signatures to place the legalization of medical access to marijuana for therapeutic purposes on the ballot in Missouri in November of 2018.
A bipartisan coalition of over two-dozen federal lawmakers, including House Judiciary Chairman Bob Goodlatte (R-VA) and Matt Gaetz (R-FL), are backing newly introduced legislation — The Medical Cannabis Research Act of 2018 — to facilitate federally-approved clinical trials involving cannabis. Passage of this act would end the University of Mississippi’s existing monopoly on the growth of cannabis for clinical research purposes by requiring the licensing of additional manufacturers.